-
Loading metrics
Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis
- Andrew R. Moore,
- Malcolm Boyce,
- Islay A. Steele,
- Fiona Campbell,
- Andrea Varro,
- D. Mark Pritchard
x
- Published: November 1, 2013
- https://doi.org/10.1371/annotation/4afd48b1-8dc0-47cc-9c8a-99aba7623116